Trial Profile
Doripenem Intrapulmonary Pharmacokinetics in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2013
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Pharmacokinetics
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 28 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 28 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.